Originally published In Press as doi:10.1074/jbc.M001336200 on April 25, 2000
J. Biol. Chem., Vol. 275, Issue 25, 19428-19432, June 23, 2000
Differential Expression of B1-containing Transcripts in
Leishmania-exposed Macrophages*
Yukiko
Ueda
and
Gautam
Chaudhuri§
From the Departments of Microbiology and Biochemistry, School of
Medicine, Meharry Medical College, Nashville, Tennessee 37208
Received for publication, February 16, 2000, and in revised form, April 24, 2000
 |
ABSTRACT |
When the parasitic protozoan
Leishmania infect host macrophage cells, establishment of
the infection requires alteration in the expression of genes in both
the parasite and the host cells. In the early phase of infection of
macrophages in vitro, Leishmania exposure
affects the expression of a group of mouse macrophage genes containing
the repetitive transposable element designated B1 sequence. In
Leishmania-exposed macrophages compared with unexposed macrophages, small (~ 0.5 kilobase) B1-containing RNAs (small B1-RNAs) are down-regulated, and large (1-4 kilobases) B1-containing RNAs (large B1-RNA) are up-regulated. The down-regulation of small B1-RNAs precedes the up-regulation of large B1-RNAs in
Leishmania-exposed macrophages. These differential
B1-containing gene expressions in Leishmania-exposed
macrophages were verified using individual small-B1-RNA and large
B1-RNA. The differential expressions of the B1-containing RNAs at the
early phase of Leishmania-macrophage interaction may
associate the establishment of the leishmanial infection.
 |
INTRODUCTION |
Protozoan parasites of the genus Leishmania cause a
diverse group of human diseases designated leishmaniasis, which affects over 12 million individuals annually in over 80 countries (1). Leishmania are transmitted from infected sandfly vectors to
the mammalian hosts when the fly takes a blood meal (1).
Leishmania exist as extracellular flagellated promastigotes
in the fly, and as intracellular non-motile amastigotes in host
macrophages (1). Amastigotes multiply and kill macrophages when the
infection is established.
There seem to be two key steps in establishing the leishmanial
infection: the expression of the virulent factors on the
Leishmania (1-8), and interference with the immune response
of the macrophages (9-13). Leishmania promastigotes express
surface molecules such as gp63 and lipophosphoglycan (1-8), which may
act as the virulent factors. Lipophosphoglycan and gp63, for example,
participate in (i) binding the macrophages, (ii) phagocytosis by
macrophages, and (iii) protecting Leishmania from lysis by
complement factors, from damages caused by reactive oxygen species, and
from proteolysis by hydrolytic enzymes in macrophage phagolysosomes
(1-8). Leishmania also affect the expression of cytokines
and the activation of the helper T lymphocytes in macrophages in order
to suppress the macrophage inflammatory responses (9-13). When
leishmanial infection is established, the expression of
pro-inflammatory cytokines such as interleukin
(IL)1 1
and IL-12 are
decreased, and anti-inflammatory cytokines such as IL-10 and
transforming growth factor
are increased (9-13). These altered
cytokine expressions involve the response of T helper lymphocyte 2 (Th2) and inactivate the Th1 response, leading to the suppression of
the inflammatory response of macrophages during the leishmanial
infection (9-13). It is, however, not known what gene expressions
initiate to trigger these immune responses in the establishment of
leishmanial infection.
This study shows that B1-containing RNAs in mouse macrophages are
regulated in the early phase of Leishmania-macrophage
interaction. The mammalian genome commonly contains small
interspersed repetitive elements (SINEs) such
as the B1 sequence in rodents and the Alu sequence in primates
(14-17). In rodent chromosomes, B1 sequences are about 150 base pairs
(bp), consist of around 80,000 repetitive transposable elements (14),
and are highly homologous with the Alu sequence in primates (15). SINEs
emerged about 60 million years ago, which is also considered the time
when mammals emerged, and have rapidly diverged in each mammalian
species (18). The ancestor sequence of SINEs is known as the
7SL-RNA, which is the RNA component in the signal recognition particle
participating in the transport of newly synthesized proteins from the
cytoplasm to the endoplasmic reticulum (19-21).
SINEs are known to be transcribed into two types of SINE-containing
RNAs: small SINE-containing RNAs such as small B1-RNAs, and large
SINE-containing RNAs such as large B1-RNAs (22-36). The small
SINE-RNAs are known to be synthesized by polymerase III (pol III),
which recognizes the internal promoter elements inside the SINE
sequence. The small SINE-RNAs usually contain many sizes of 5'-flanking
regions (22), so that the sizes of pol III-directed small B1-RNAs, for
example, range from 0.2 to 0.4 kilobases (23). Since these SINE-RNAs
are associated with polyadenylated nuclear RNAs and heterogeneous
nuclear RNAs, their role is thought to be related to the processing of
other RNAs (24, 25). Small SINE-RNAs are not only transcribed, but are also processed as small cytoplasmic poly(A)+ SINE-RNAs (23,
26). The expression of the poly(A)+ small Alu-RNAs are
known to increase in cells after such stresses as heat shock (27),
inhibition of protein synthesis (27), viral infection (28, 29), and UV
irradiation (30). These poly(A)+ small Alu-RNAs are also
shown as inhibitors of RNA-dependent protein kinase (PKR)
(31). The activated PKR phosphorylates eukaryotic translation
initiation factor 2, leading to the inhibition of translation; it also
phosphorylates inhibitor of nuclear factor-
B, leading to activation
of the transcription of many genes (32). Despite these studies, the
role of small B1-RNAs is not clearly defined. SINEs also exist at the
3'-UTR of some pol II transcripts such as large B1-RNAs and large
Alu-RNAs (33-36). The role of the SINEs in the 3'-UTR is also not
clear, although some evidence suggests that B1 sequences enhance the
stability of pol II transcripts (36).
The extent to which early gene expression leads to the establishment of
leishmanial infection is poorly understood. In the present study, the
expression of B1-containing RNAs was studied in
Leishmania-exposed macrophages in an attempt to understand the role of differential macrophage gene expression in the
establishment of leishmanial infection.
 |
EXPERIMENTAL PROCEDURES |
Cell Cultures--
Leishmania amazonensis (LV78) and
mouse macrophage cells (J774G8) were obtained from Dr. K.-P. Chang
(Chicago Medical School, Chicago, IL). Leishmania
promastigotes were maintained at 25 °C in Medium 199 (Life
Technologies, Inc.) containing 10% heat-inactivated fetal bovine serum
(37, 38). Monolayers of cultured macrophage cells were incubated at
37 °C with Leishmania promastigotes (ratio of
macrophage:Leishmania = 1:10) for 1-6 h in RPMI 1640 medium (Life Technologies, Inc.) containing 20% heat-inactivated fetal bovine serum (37, 38).
Isolation of RNA--
Total macrophage RNA was isolated using
the Promega RNAgents total RNA isolation system. The isolated RNA
(1-1.5 mg) was treated with 0.1 unit/ml RNase-free DNase I (Life
Technologies, Inc.) for 30 min at 37 °C in a mixture of 10 units of
human placental RNase inhibitor, 10 mM Tris-HCl, pH 8.3, 50 mM KCl, and 2.5 mM MgCl2. The RNAs
were then extracted with phenol/chloroform (3:1), precipitated with
ethanol, and eluted with H2O.
DD-RT-PCR Analysis--
An aliquot (0.3 µg) of DNase-treated
RNA was denatured at 65 °C for 5 min in a 30-µl mixture of 50 mM Tris-HCl, pH 8.3, 75 mM KCl, 3 mM MgCl2, 10 mM DTT, 51.3 µM each dNTP, 3 µM dinucleotide-anchored oligo(dT) primers. This mixture was incubated at 37 °C for 10 min to
allow the primer to anneal, and then incubated with Superscript II
reverse transcriptase (Life Technologies, Inc.) for 1 h at 37 °C. This mixture was then incubated at 95 °C for 5 min to
inactivate the reverse transcriptase. An aliquot of the synthesized
cDNA (1 µl) was used in 20 µl of the cDNA amplification in
a mixture of 0.5 µM arbitrary primers (10-mers), 2.5 µM dinucleotide-anchored oligo(dT) primers, 2 µM each of dGTP, dTTP, and dCTP, 10 µCi of [
-33P]dATP, 0.5 unit of AmpliTaq DNA polymerase
(Perkin-Elmer) with the following PCR conditions: 5 cycles (30 s
(94 °C), 1 min (40 °C), and 1 min (72 °C)), 35 cycles (30 s
(94 °C), 1 min (42 °C), and 1 min (72 °C)), and 1 cycle (10 min (72 °C)) (39-41). The PCR products (4 µl) were denatured for
2 min at 80 °C and loaded onto 6% denaturing polyacrylamide gels.
The gels were run at 75 watts for 2 h, dried onto Whatman 3MM
paper, and exposed to x-ray film for 48 h at
70 °C. The
amplified 3'-region of cDNAs designated 3'-expressed sequence tags
(ESTs) were identified on the autoradiogram, excised from dried gel,
and rehydrated in 100 µl of water at 100 °C for 15 min. The
dissolved 3'-ESTs were amplified by two rounds of PCR in the same
condition as described above. The amplified products were
electrophoresed in 2% low melting agarose gel, purified, subcloned
into the pCR-II plasmid vector (Invitrogen), and sequenced.
Northern Blot Analysis--
The isolated total RNAs (5 µg)
from Leishmania-exposed and -unexposed macrophages were
electrophoresed on a 1.2% formaldehyde agarose gel (42), transferred
onto a nylon membrane (Schleicher & Schuell), and hybridized with the
following probes using Rapid-hyb Buffer (Amersham Pharmacia Biotech).
To make a probe from a differentially expressed 3'-EST named YU7-EST in
DD-RT-PCR, 25 ng of YU7-EST was excised from the pCR-II plasmid vector,
purified, and labeled with [
-32P]dCTP (NEN Life
Science Products) using the Random Primer labeling system (Life
Technologies, Inc.). Un-incorporated dNTPs were removed by
centrifugation through Sephadex G-50 spin column (Amersham Pharmacia
Biotech). To make the transcription factor IIS (TFIIS) probe, the
coding region (720 bp) of TFIIS was amplified by PCR using a primer set
(5'-CCTCGGGCACCAAGCACTTC-3' and 5'-GCTGATCTGAGACCCAGAAGGC-3') and the
templates, reverse transcribed macrophage cDNAs. These primers were
designed from the TFIIS sequence in Ehrlich ascites tumor cells
described by Hirashima et al. (43). The labeling method was
the same as that for YU7-EST. To make the B1 probe, B1 sequence of
YU7-EST was amplified by PCR using a primer set (5'-TGGTGGGACACGCCTTTAATC-3' and 5'-TTTTTGGGGATGGGAGGGTTC-3') and the
template, YU7-EST recombinant pCR-II. The amplified B1 sequence (150 bp) was cloned into pCR-II vectors, and labeled using the PCR labeling
system (Life Technologies, Inc.). To make gene-specific probe,
gene-specific region of YU7-EST was amplified using a primer set
(5'-GGTCATAGCACTAGATTCGGAAGC-3' and 5'-TTAAAGGCGTGTCCCAC CACAC-3'),
cloned into pCR-II vectors, and labeled with the same method as in the
labeling of the B1 probe.
Macrophage Library Screening--
mRNAs were isolated from
J774G8 macrophage cells using QuickPrep micro mRNA purification kit
(Amersham Pharmacia Biotech); cDNAs were then synthesized using ZAP
Express cDNA synthesis kit (Stratagene). The cDNAs were cloned
into a phage vector, ZAP Express (Stratagene). The constructed library
was screened by using the TFIIS probe.
5'-Rapid Amplification of cDNA End (RACE)--
The 5'-RACE
was performed by using the protocol provided by Life Technologies,
Inc., with the following modifications. The total RNA (1 µg) was
reverse transcribed using two primers synthesized from YU7-EST: (i)
5'-TTTTTGGGGGATGGGAGGGTTC-3' designed from the region between the B1
sequence and the poly(A)+ region, and (ii)
5'-GTGATTTCTTAGAACACTGAGAACAGCTTG-3' designed from the gene-specific
region. These two primers generate two kinds of cDNA pools in the
reverse transcriptase reaction. These cDNA pools were purified with
the Sephadex G-50 column (Amersham Pharmacia Biotech) to eliminate
these primers and to recover small (under 500 base pairs) cDNAs.
These two kinds of cDNA pools were tailed by adding cytosine
residues at the 5' ends by using terminal transferase (Life
Technologies, Inc.), and amplified by PCR using a primer set
(5'-CACTGAGAACAGCTTGAGAAAG-3' designed from YU7-EST and oligo(G)-linked
amplification primer provided by Life Technologies, Inc.). PCR was
performed in a reaction mixture containing 0.5 µM of each
primer, 200 µM each dGTP, dTTP, dATP, and dCTP, 0.5 unit
of AmpliTaq DNA polymerase (Perkin-Elmer) with the following conditions: 1 cycle (2 min (94 °C)), 35 cycles (1 min (94 °C), 1 min (55 °C), 2 min (72 °C)), and 1 cycle (7 min (72 °C)). The primary PCR products were further amplified by a nested gene-specific primer (5'-GCTTCCGAATCTAGTGCTATG-3') designed from YU7-EST and the
amplification primer without the oligo(G) anchor (Life Technologies, Inc.). The secondary PCR products were purified, cloned into pCR-II (Invitrogen), and sequenced.
RT-PCR Analysis--
DNase-treated total RNA (5 µg) from
Leishmania-exposed and -unexposed macrophages were reverse
transcribed using oligo(dT) primers as described above for the
DD-RT-PCR analysis. The synthesized cDNAs (1 µl) were amplified
by PCR using the following primer set: FP
(5'-CCTTTCACATGGTTGCCCAAG-3'), forward primer from 5'-RACE product and
CP (5'-CTTCCGAATCTAGTGCTATGACCC-3'), reverse primer from the connecting
region between YU7-EST and the 5'-RACE product. The other reverse
primer, BP (5'-TCGAACGCAGAAATCTGCCCG-3') from the B1 region of YU7-EST,
was also used with the forward primer to amplify the cDNAs. The
amplification condition was the same as that of the PCR amplification
used in the 5'-RACE described above.
 |
RESULTS |
Leishmania-exposed Macrophages Contain Less YU7-EST than Control
Macrophages--
To analyze differential gene expressions in the early
phase of leishmanial infection, poly(A)+ RNAs in
Leishmania-exposed and -unexposed mouse macrophages were compared by DD-RT-PCR analysis. The autoradiogram of DD-RT-PCR showed
that a 3'-EST designated YU7-EST was amplified in control macrophages,
but not in Leishmania-exposed macrophages (Fig.
1A). The YU7-EST was subcloned
and sequenced (Fig. 1B). The underlined nucleotides in Fig. 1B are the arbitrary primer sequence
(5'-TCGGTCATAG-3') and the complementary sequence of the
dinucleotide-anchored oligo(dT) primer (5'-TTTTTTTTTTTGG-3'), which
were used for cDNA amplification in the DD-RT-PCR analysis.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 1.
DD-RT-PCR analysis showing B1-containing
3'-EST, YU7-EST, in the control macrophages but not in
Leishmania-exposed macrophages. A,
autoradiogram of DD-RT-PCR. Total RNAs (0.3 µg) from
Leishmania-exposed and -unexposed mouse macrophages were
compared using DD-RT-PCR analysis. One of the 3'-EST, designated
YU7-EST, was amplified by DD-RT-PCR in the control macrophages
(lane M), not in Leishmania-exposed
macrophages (lane L+M). B, the
nucleotide sequence of YU7-EST. YU-7-EST was recovered from
polyacrylamide gel in DD-RT-PCR analysis, and the nucleotides were
sequenced. Underlined nucleotides are 10-mer of the
arbitrary primer and the complementary sequence of
dinucleotide-anchored oligo(dT)primer used in DD-RT-PCR analysis.
C, the schematic representation of YU7-EST. YU7-EST contains
gene-specific sequence at 5' end and B1 sequence at the 3' end just
before poly(A)+ tail.
|
|
YU7-EST Contains B1 Sequence at the 3' End--
YU7-EST has a
homologous region with more than 7,000 mouse gene sequences detected in
GenBankTM; this homologous region was identified as B1 sequences. The
components of YU7-EST are 105 bp of gene-specific region, 151 bp of B1
sequence, and 11 bp of part of poly(A)+ region (Fig. 1,
B and C). The gene-specific region did not have any significant homology with sequences in GenBankTM.
Small B1-RNAs Are Down-regulated, and Large B1-RNAs Are
Up-regulated in Leishmania-exposed Macrophages--
YU7-EST was used
as a probe in Northern analysis to compare the hybridization pattern
with total RNAs from Leishmania-exposed and -unexposed
macrophages. As shown in Fig.
2A, the YU7-EST probe hybridized with many RNA species, but hybridizing RNAs were somewhat different in size in the Leishmania-exposed
versus -unexposed macrophage RNAs: small (~0.5 kilobase)
RNAs (small B1-RNAs) were down-regulated and large (1-4 kilobases)
RNAs (large B1-RNAs) were up-regulated, when macrophages were exposed
to Leishmania for 2 h (Fig. 2A).

View larger version (54K):
[in this window]
[in a new window]
|
Fig. 2.
Small B1-RNAs are down-regulated, and large
B1-RNAs are up-regulated in Leishmania-exposed
macrophages. A, Northern blot analysis with YU7-EST as
a probe. Upper panel, ethidium bromide-stained
RNAs in formaldehyde agarose gel. M, control macrophages;
L, Leishmania-exposed macrophages (2-h exposure).
Lower panel, Northern autoradiogram. The
transferred RNAs from agarose gel onto the nylon membrane were
hybridized with YU7-EST probe. B, Northern blot analysis with B1 probe
at different times after Leishmania exposure.
Upper panel, ethidium bromide-stained RNAs in
formaldehyde agarose gel. Macrophages (106 cells) were
exposed to Leishmania (107 cells) for 1, 2, 4, and 6 h. Lower panel, Northern
autoradiogram. The transferred RNAs on the nylon membrane were
hybridized with the B1 probe.
|
|
To analyze the hybridization pattern further, the gene-specific
sequence and the B1 sequence of YU7-EST were separately hybridized with
RNAs isolated from macrophages which were exposed to
Leishmania for up to 6 h. Northern analysis with the B1
probe (Fig. 2B) showed a hybridization pattern similar to
that in Fig. 2A; small B1-RNAs were down-regulated, and
large B1-RNAs were up-regulated in Leishmania-exposed macrophages. The up-regulation of large B1-RNAs in Northern analysis with the YU7-EST probe (Fig. 2A) is more striking than that
seen in Northern analysis with the B1 probe (Fig. 2B). This
time-course experiment showed that the down-regulation of small B1-RNAs
occurred prior to the up-regulation of large B1-RNAs in
Leishmania-exposed macrophages (Fig. 2B).
Northern analysis with the gene-specific probe did not show any
significant hybridization on the Northern autoradiogram.
The Full Length of the YU7-RNA--
By using 5'-RACE analysis, the
extended 5'-region of YU7-EST was identified to be 147 bp (Fig.
3A); the full length of the YU7-RNA transcript was estimated to be 398 bases by connecting the
nucleotide sequences of 5'-RACE product and YU7-EST (Fig. 3B). RT-PCR was performed to confirm whether this expected
YU7-RNA exists in macrophages. The primer sets FP/BP and FP/CP
generated the expected sizes of PCR products (Fig. 3C).
These products were sequenced and confirmed to be part of
YU7-cDNAs. As shown in Fig. 3C, these RT-PCR products
were down-regulated in Leishmania-exposed macrophages. This
result confirmed that YU7-RNA is one of the small B1-RNAs, and
supported the data in Fig. 2. In the B1 sequence of the YU7-RNA, the
putative A-box (5'-GGTGTGGT-3') and B-box (5'-GTTCGAGGC-3') for the pol
III promoter region were identified by alignment with 10 other known
cytoplasmic polyadenylated small B1-RNAs described by Maraia et
al. (44).

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 3.
Characterization of YU7-RNA.
A, nucleotide sequences of 5'-RACE product (147 bp) and the
primer from YU7-EST used in the 5'-RACE. The reverse primer from
YU7-EST was extended on the cDNA templates that were reverse
transcribed from DNase-treated total macrophage RNAs. The extended
fragment was amplified, cloned into a cloning vector, and sequenced.
B, full length of the transcript, YU7-RNA, was calculated to
be 398 bases by connecting the 5'-RACE product and YU7-EST. On this
expected YU7-RNA, four primers were designed for RT-PCR: FP, forward
primer from the 5'-RACE product; CP, reverse primer designed from the
connection between the 5'-RACE product and YU7-EST; BP, reverse primer
designed from B1 sequence; RP, oligo(dT) primer. C, ethidium
bromide-stained RT-PCR product in agarose gel. Total RNAs were reverse
transcribed with the oligo(dT) primer, RP. The synthesized cDNAs
were amplified with two primer sets, FP/BP and FP/CP. Both RT-PCR
amplifications generated 314- and 164-bp bands, as expected.
S, 100-bp ladder DNA size standard.
|
|
A Large B1-RNA, TFIIS mRNA, Is Overexpressed in
Leishmania-exposed Macrophages--
To verify the overexpression of
the large B1-containing RNAs in the Leishmania-exposed
macrophages, TFIIS, a general transcription elongation factor, was
selected as a representative of pol II-directed large B1-RNA from the
BLAST result list aligned with YU7-EST, because some TFIIS isoforms
contain the B1 sequence at the 3'-UTR (43, 45-48). To analyze the
expression of the TFIIS in the macrophages of our experimental system,
macrophage cDNA library was constructed using J774G8 mRNAs, and
then screened with the TFIIS probe. The library screening confirmed
that the majority of the TFIIS mRNAs in J774G8 cells contained B1
sequence at the 3'-UTR. Northern analysis with TFIIS probe showed that
the TFIIS mRNA was up-regulated in the
Leishmania-exposed macrophages (Fig.
4). These data are consistent with the
idea that small B1-RNAs are decreased while large B1-RNAs are increased
in macrophages during the early phase of leishmanial interaction.

View larger version (37K):
[in this window]
[in a new window]
|
Fig. 4.
Up-regulation of TFIIS in
Leishmania-exposed macrophages. A,
ethidium bromide-stained macrophage RNAs in formaldehyde agarose gel.
B, Northern autoradiogram with TFIIS probe. The transferred
RNAs from agarose gel onto the nylon membrane were originally
hybridized with YU7-EST probe (Fig. 2A). The YU7-EST probe
was stripped from the RNA blot and re-hybridized with the TFIIS
probe.
|
|
 |
DISCUSSION |
It has been thought that the many repeats of SINEs such as B1 and
Alu sequences serve some physiological roles, but this has not been
proven (49). Two important findings were established by this study
relating to the SINE-RNAs. First, the pool size of small B1-RNAs is
down-regulated in Leishmania-exposed mouse macrophages.
Second, the pool size of the pol II-directed large B1-RNAs is
up-regulated in Leishmania-exposed macrophages. The down-regulation of small B1-RNAs preceeds the up-regulation of large
B1-RNAs, and this alteration occurs within a short period (1-6 h) of
Leishmania-macrophage co-incubation. The mechanisms underlying the regulation of small and large B1-RNAs were not explored
in this study. However, the stabilization of SINE-RNAs has been
reported to result from the functional alteration of chromatin
structure (50), strength of the internal promoter (26), DNA methylation
(51), and posttranscriptional stabilization (52). The rapid and
transient macrophage gene expressions during the early phase of
leishmanial infection have not been extensively reported.
There is evidence that the pool size of small SINE-RNAs is altered when
cells are treated with specific conditions (28, 29, 52). In
virus-infected cells, for example, small Alu-RNAs are up-regulated in
human cells (28, 29). When cells are incubated with wild type p53 (a
tumor suppresser protein), the small Alu-RNAs are down-regulated (52).
Chu et al. (31) also showed evidence indicating that small
Alu-RNAs have a potential to be inhibitors for PKR. PKR is known to be
induced in stressed cells by such factors as UV irradiation and viral
infection (32, 53). The activated PKR phosphorylates eukaryotic
translation initiation factor and inhibitor of nuclear factor-
B
(32). In this manner, the activated PKR inhibits translation and
stimulates the transcription in host cells. The activation of PKR seems
to be needed for the inhibition of the viral protein translation for
host survival, and viruses indeed possess the mechanism to inhibit the
activation of PKR for their survival (54). The transient increase of
the small Alu-RNAs after viral infection seems to inhibit the PKR, which may bring the cells back to their normal state. It is intriguing to speculate that the increase in small SINE-RNAs may be related to the
recovery of "damaged cells" to "normal cells." For example, the
decrease in small B1-RNAs during leishmanial interaction may be a
signal for damaged cells, such that the decrease of the small B1-RNAs
may inhibit the recovery from damaged cells to normal cells.
Leishmanial interaction may inhibit the induction of the small B1-RNAs
in macrophages; this would keep macrophages in a non-viable state while
leishmanial infection is established. However, not much detail is known
about how leishmanial interaction affects the down-regulation of these
pol III-directed synthesis of small B1-RNAs in macrophages. The
knowledge of this mechanism will be helpful in our understanding of how
Leishmania sends signals to macrophages at the initial phase
of infection.
Concerning pol II-directed transcripts, many have the B1 sequence
mainly at the 3'-UTR (33-36). The role of the B1 sequence at the
3'-UTR is not clear, although some evidence suggests that it enhances
the stability of pol II transcripts (36). We selected TFIIS as a
representative of the large B1-RNAs because TFIIS is general
transcription factor (43, 45-48) and TFIIS mRNA is expected to be
commonly expressed in many cell types.
Do the down-regulation of small B1-RNAs and the up-regulation of large
B1-RNAs involve B1-binding proteins in Leishmania-exposed mouse macrophages? It has been reported that the families of SINE-RNAs have conserved secondary structures (18, 19, 44), which serve as
binding sites for SINE-binding proteins (55-59). In our experimental
system, the expression of the small B1-RNAs was abundant in the control
macrophages compared with that in Leishmania-exposed macrophages. This observation may indicate that most of B1-binding proteins are occupied on the small B1-RNAs in control macrophages. Hypothetically, a decrease of small B1-RNAs in
Leishmania-exposed macrophages may make more B1-binding
proteins available in the macrophage cytoplasm; these could then bind
to the B1 sequence at the 3'-UTR of pol II transcripts and stabilize
them in Leishmania-exposed macrophages.
 |
ACKNOWLEDGEMENT |
We thank Angelika K. Parl for technical assistance.
 |
FOOTNOTES |
*
This work was supported by National Institutes of Health
Grants 5-R01AI42327-03 and 2S06GM08037-24 (to G. C.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Current affiliation: Div. of Hematology/Oncology, Vanderbilt
University, Nashville, TN 37232-5536.
§
To whom correspondence should be addressed: Dept. of Microbiology,
School of Medicine, Meharry Medical College, 1005 D. B. Todd Jr.
Blvd., Nashville, TN 37208. Tel.: 615-327-6499; Fax: 615-327-5559;
E-mail: gchaudhuri@mail.mmc.edu.
Published, JBC Papers in Press, April 25, 2000, DOI 10.1074/jbc.M001336200
 |
ABBREVIATIONS |
The abbreviations used are:
IL, interleukin;
SINE, short interspersed element;
bp, base pair(s);
PCR, polymerase
chain reaction;
DD-RT-PCR, differential display reverse
transcriptase-PCR;
RT-PCR, reverse transcriptase-PCR;
EST, expressed
sequence tag;
TFIIS, transcription factor IIS;
5'-RACE, 5'-rapid
amplification of cDNA end;
pol II, RNA polymerase II;
pol III, RNA
polymerase III;
PKR, RNA-dependent protein kinase;
UTR, untranslated region.
 |
REFERENCES |
| 1.
|
Chang, K.-P.,
and Hendricks, L. D.
(1985)
in
Leishmaniasis
(Chang, K. P.
, and Bray, R. S., eds)
, pp. 213-244, Elsevier Science Publishers, New York
|
| 2.
|
Chaudhuri, G.,
and Chang, K. P.
(1988)
Mol. Biochem. Parasitol.
27,
43-52
|
| 3.
|
Etges, R.,
Bouvier, J.,
and Bordier, C.
(1986)
J. Biol. Chem.
261,
9098-9101
|
| 4.
|
Chang, K.-P.,
Chaudhuri, G.,
and Fong, D.
(1990)
Annu. Rev. Microbiol.
44,
499-529
|
| 5.
|
Chang, C. S.,
and Chang, K.-P.
(1986)
Proc. Natl. Acad. Sci. U. S. A.
83,
100-104
|
| 6.
|
Chan, J.,
Fujiwara, T.,
Brennan, P.,
McNeil, M.,
Turco, S. J,
Sibille, J,-C.,
Snapper, M.,
Aisen, P.,
and Bloom, B. R.
(1989)
Proc. Natl. Acad. Sci. U. S. A.
86,
2453-2457
|
| 7.
|
Cooper, A.,
Rosen, H.,
and Blackwell, J. M.
(1988)
Immunology
65,
511-514
|
| 8.
|
Da Silva, R. P.,
Hall, B. F.,
Joiner, K. A.,
and Sacks, D. L.
(1989)
J. Immunol.
143,
617-622
|
| 9.
|
Huang, F. P.,
Xu, D.,
Esfandiari, E. O.,
Sands, W.,
Wei, X. O.,
and Liew, F. Y.
(1998)
J. Immunol.
160,
4143-4147
|
| 10.
|
Racoosin, E. L.,
and Beverley, M.
(1997)
Exp. Parasitol.
85,
283-295
|
| 11.
|
Blackwell, J. M.,
Black, G. F.,
Peacock, C. S.,
Miller, E. N.,
Sibthorpe, D.,
Gnananandha, D.,
Shaw, J. J.,
Silveira, F.,
Lins-Lainson, Z.,
Ramos, F.,
Collins, A.,
and Shaw, M. A.
(1997)
Philos. Trans. R. Soc. Lond. B Biol. Sci.
352,
1331-1345
|
| 12.
|
Carrera, L.,
Gazzinelli, R. T.,
Badolato, R.,
Hieny, S.,
Muller, W.,
Kuhn, R.,
and Sacks, D. L.
(1996)
J. Exp. Med.
183,
515-526
|
| 13.
|
Reiner, S. L.,
Zheng, S.,
Wang, Z.-E.,
Stowring, L.,
and Locksley, R. M.
(1994)
J. Exp. Med.
179,
447-456
|
| 14.
|
Krayev, A. S.,
Kramerov, D. A.,
Skryabin, K. G.,
Ryskov, A. P.,
Bayev, A. A.,
and Georgiev, G. P.
(1980)
Nucleic Acids Res.
8,
1201-1215
|
| 15.
|
Jelinek, W. R.,
Toomey, T. P.,
Leinwand, L.,
Duncan, C. H.,
Biro, P. A.,
Choudary, P. V.,
Weissman, S. M.,
Rubin, C. M.,
Houck, C. M.,
Deininger, P. L.,
and Schmid, C. W.
(1980)
Proc. Natl. Acad. Sci. U. S. A.
77,
1398-1402
|
| 16.
|
Davidson, E. H.,
Klein, W. H.,
and Britten, R. J.
(1977)
Dev. Biol.
55,
69-84
|
| 17.
|
Elder, J. T.,
Pan, J.,
Duncan, C. H.,
and Weissman, S. M.
(1981)
Nucleic Acids Res.
9,
1171-1189
|
| 18.
|
Labuda, D.,
Sinnett, D.,
Richer, C.,
Deregon, J.-M.,
and Striker, G.
(1991)
J. Mol. Evol.
32,
405-414
|
| 19.
|
Labuda, D.,
and Zietkiewicz, E.
(1994)
J. Mol. Evol.
39,
506-518
|
| 20.
|
Zietkiewicz, E.,
and Labuda, D.
(1996)
J. Mol. Evol.
42,
66-72
|
| 21.
|
Quentin, Y.
(1994)
Genetica
93,
203-215
|
| 22.
|
Deininger, P. L.,
Batzer, M. A.,
Hutchison, C. A., III,
and Edgell, M. H.
(1992)
Trends Genet.
8,
307-311
|
| 23.
|
Ryskov, A. P.,
Ivanov, P. L.,
Tokarskaya, O. N.,
Kremerov, D. A.,
Grigoryan, M. S.,
and Georgiev, G. P.
(1985)
FEBS Lett.
182,
73-76
|
| 24.
|
Harada, F.,
Kato, N.,
and Hoshino, H.
(1979)
Nucleic Acids Res.
7,
909-917
|
| 25.
|
Balmain, A.,
Frew, L.,
Cole, G.,
Krumlauf, R.,
Ritchie, A.,
and Birnie, G. D.
(1982)
J. Mol. Biol.
160,
163-179
|
| 26.
|
Liu, W. M.,
Maraia, R. J.,
Rubin, C. M.,
and Schmid, C. W.
(1994)
Nucleic Acids Res.
22,
1087-1095
|
| 27.
|
Liu, W. M.,
Chu, W. M.,
Choudary, P. V.,
and Schmid, C. W.
(1995)
Nucleic Acids Res.
23,
1758-1765
|
| 28.
|
Panning, B.,
and Smiley, J. R.
(1994)
Virology
202,
408-417
|
| 29.
|
Russanova, V. R.,
Driscoll, C. T.,
and Howard, B. H.
(1995)
Mol. Cell. Biol.
15,
4282-4290
|
| 30.
|
Englander, E. W.,
and Howard, B. H.
(1997)
Mutat. Res.
385,
31-39
|
| 31.
|
Chu, W. M.,
Ballard, R.,
Carpick, B. W.,
Williams, B. R.,
and Schmid, C. W.
(1998)
Mol. Cell. Biol.
18,
58-68
|
| 32.
|
Gale, M.,
Blakely, C. M.,
Hopkins, D. A.,
Melville, M. W.,
Wambach, M.,
Romano, P. R.,
and Katze, M. G.
(1998)
Mol. Cell. Biol.
18,
859-871
|
| 33.
|
Gallagher, P. M.,
D'Amore, M.,
Lund, S. D.,
and Ganschow, R. E.
(1988)
Genomics
2,
215-219
|
| 34.
|
Coggins, L. W.,
Vass, J. K.,
Stinson, M. A.,
Lanyon, W. G.,
and Paul, J.
(1982)
Gene (Amst.)
17,
113-116
|
| 35.
|
Heard, E.,
Avner, P.,
and Rothstein, R.
(1994)
Nucleic Acids Res.
22,
1830-1837
|
| 36.
|
Vidal, F.,
Mougneu, E.,
Glaichenhaus, N.,
Vaigot, P.,
Darmon, M.,
and Cuzin, F.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
90,
208-212
|
| 37.
|
Liu, X.,
and Chang, K.-P.
(1992)
Proc. Natl. Acad. Sci. U. S. A.
89,
4991-4995
|
| 38.
|
Chang, K.-P.
(1980)
Science
209,
1240-1242
|
| 39.
|
Liang, P.,
and Pardee, A. B.
(1992)
Science
257,
967-971
|
| 40.
|
Liang, P.,
Averboukh, L.,
and Pardee, A. B.
(1993)
Nucleic Acids Res.
21,
3269-3275
|
| 41.
|
Heard, P. L.,
Lewis, C. S.,
and Chaudhuri, G.
(1996)
J. Eukaryot. Microbiol.
43,
409-415
|
| 42.
|
Sambrook, J.,
Fritsch, E. F.,
and Maniatis, T.
(1989)
Molecular Cloning: A Laboratory Manual
, 2nd Ed.
, Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
|
| 43.
|
Hirashima, S.,
Hirai, H.,
Nakanishi, Y.,
and Natori, S.
(1988)
J. Biol. Chem.
263,
3858-3863
|
| 44.
|
Maraia, R. J.
(1991)
Nucleic Acids Res.
19,
5695-5702
|
| 45.
|
Johnson, T. L.,
and Chamberlin, M. J.
(1994)
Cell
77,
217-224
|
| 46.
|
Krauskopf, A.,
Ben-Asher, E.,
and Aloni, Y.
(1994)
J. Virol.
68,
2741-2745
|
| 47.
|
Jeon, C.,
and Agarwal, K.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
13677-13682
|
| 48.
|
Morin, P. E.,
Away, D. E.,
Edwards, A. M.,
and Arrowsmith, C. H.
(1996)
Proc. Natl. Acad. Sci. U. S. A.
93,
10604-10608
|
| 49.
|
Schmid, C. W.,
and Maraia, R. J.
(1992)
Curr. Opin. Genet. Dev.
2,
874-882
|
| 50.
|
Chu, W. M.,
Liu, W. M.,
and Schmid, C. W.
(1995)
Nucleic Acids Res.
23,
1750-1757
|
| 51.
|
Englander, E. W.,
Wolffe, A. P.,
and Howard, B. H.
(1993)
J. Biol. Chem.
268,
19565-19573
|
| 52.
|
Chesnokov, I.,
Chu, W. M.,
Botchan, R.,
and Schmid, C. W.
(1996)
Mol. Cell. Biol.
16,
7084-7088
|
| 53.
|
Clements, M. J.
(1997)
Int. J. Biochem. Cell Biol.
29,
945-949
|
| 54.
|
Gale, M.,
Blakely, C. M.,
Kwieciszewski, B.,
Tan, S. L.,
Dossett, M.,
Tang, N. M.,
Korth, M. J.,
Polyak, S. J.,
Gretch, D. R.,
and Katze, M. G.
(1998)
Mol. Cell. Biol.
18,
5208-5218
|
| 55.
|
Chang, D.-Y.,
Hsu, K.,
and Maraia, R. J.
(1996)
Nucleic Acids Res.
24,
4165-4170
|
| 56.
|
Chang, D.-Y.,
and Maraia, R. J.
(1993)
J. Biol. Chem.
268,
6423-6428
|
| 57.
|
Chang, D.-Y.,
Nelson, B.,
Bilyeu, T.,
Hsu, K.,
Darlington, G.,
and Maraia, R. J.
(1994)
Mol. Cell. Biol.
14,
3949-3959
|
| 58.
|
Craig, A. W.,
Svitkin, Y. V.,
Lee, H. S.,
Belsham, G. J.,
and Sonenberg, N.
(1997)
Mol. Cell. Biol.
17,
163-169
|
| 59.
|
Costeas, P. A.,
Tonelli, L. A.,
and Chinsky, J. M.
(1996)
Biochim. Biophys. Acta
1305,
25-28
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
S. Misra, M. K. Tripathi, and G. Chaudhuri
Down-regulation of 7SL RNA Expression and Impairment of Vesicular Protein Transport Pathways by Leishmania Infection of Macrophages
J. Biol. Chem.,
August 12, 2005;
280(32):
29364 - 29373.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.